SN
Therapeutic Areas
AKIGAI Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EGFR Inhibitor (Tyrosine Kinase Inhibitor - oral) | Chronic Neuropathic Pain | Preclinical |
| EGFR Inhibitor (Monoclonal Antibody - parenteral) | Chronic Neuropathic Pain | Preclinical |
| Modified/Targeted EGFR Inhibitor | Chronic Neuropathic Pain | Discovery |
Leadership Team at AKIGAI
CK
Christian Kersten
MD PhD, Co-Founder, Clinical Oncologist, Researcher, Inventor
MC
Marte Cameron
MD PhD, Co-Founder, Clinical Oncologist, Researcher, Inventor
GS
Gry Stensrud
Chief Technical Officer (CTO) & Chief Organizational Officer (COO)
MK
Morten Kompen
Chief Financial Officer (CFO)
GE
Gunnar Evensen
Board Member and Investor
GA
Gerard Akkerhuis
MD, Business Development Advisor